Top Markets
Coin of the day
GemVax&KAEL Co.,Ltd GemVax&KAEL Co.,Ltd

GemVax&KAEL Co.,Ltd

082270
Classificação em ações #15775
GemVax & KAEL Co., Ltd. specializes in manufacturing chemical filtration... GemVax & KAEL Co., Ltd. specializes in manufacturing chemical filtration systems and gas purification units, primarily for the semiconductor industry. The company operates through two main segments: Environmental Pollution Control and Bio Business. Its Environmental Pollution Control division focuses on creating essential filters for semiconductor and display fabrication processes, in addition to developing equipment for air quality management and odor prevention. Concurrently, the Bio Business division is dedicated to advancing its innovative telomerase-derived peptide drug, GV1001, through preparations for domestic and international Phase 2 and 3 clinical trials. These trials are designed to address various conditions, including Alzheimer's disease, benign prostatic hyperplasia, and progressive supranuclear palsy. Founded on March 10, 1998, GemVax & KAEL Co., Ltd. is headquartered in Daejeon, South Korea.
Preço da ação
$7.54
Valor de mercado
$331.60M
Variação (1 dia)
-3.79%
Variação (1 ano)
-75.66%
País
KR
Negociar GemVax&KAEL Co.,Ltd (082270)

Categoria

EPS de GemVax&KAEL Co.,Ltd (082270)
EPS em 2026 TTM: 0
De acordo com os últimos relatórios financeiros e o preço das ações da GemVax&KAEL Co.,Ltd, o EPS atual da empresa (TTM) é 0. No final de 2026, a empresa teve um EPS de 0, igual a ao EPS de 2026, que foi de 0.
Histórico de EPS da GemVax&KAEL Co.,Ltd de 2026 até 2026
EPS no final de cada ano
Ano EPS Alterar
Não há dados suficientes para as datas fornecidas.
EPS de empresas semelhantes ou concorrentes